Ford, Matthew M. http://orcid.org/0000-0002-1204-1980
George, Brianna E. http://orcid.org/0000-0002-5234-0889
Van Laar, Victor S. http://orcid.org/0000-0001-5789-2191
Holleran, Katherine M.
Naidoo, Jerusha
Hadaczek, Piotr
Vanderhooft, Lauren E.
Peck, Emily G. http://orcid.org/0000-0002-2024-8930
Dawes, Monica H. http://orcid.org/0000-0002-4729-5526
Ohno, Kousaku
Bringas, John
McBride, Jodi L.
Samaranch, Lluis
Forsayeth, John R.
Jones, Sara R.
Grant, Kathleen A. http://orcid.org/0000-0002-0380-7219
Bankiewicz, Krystof S. http://orcid.org/0000-0002-0424-3566
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01 AA024757, P60 AA010760, U01 AA014091, P50 AA026117, U01 AA013510, P60 AA010760, R24 AA019431)
Article History
Received: 12 October 2022
Accepted: 15 June 2023
First Online: 14 August 2023
Competing interests
: K.S.B. is a consultant for Asklepios BioPharmaceutical, Scribe Therapeutics and Aviado Bio. The remaining authors declare no competing interests.